LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 55.48 | 84.90 | 4352 | 6567 | 0.6626 | 0.8730 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 55.48 | 84.90 | 1110 | 6567 | 0.1690 | 0.5065 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 55.48 | 84.90 | 5695 | 6567 | 0.8671 | 0.9551 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 57.18 | 84.90 | 2254 | 6963 | 0.3237 | 0.6749 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 57.18 | 84.90 | 4513 | 6963 | 0.6481 | 0.8681 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 57.18 | 84.90 | 972 | 6963 | 0.1396 | 0.4673 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 57.18 | 84.90 | 5880 | 6963 | 0.8444 | 0.9475 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 58.88 | 84.90 | 2235 | 7291 | 0.3065 | 0.6638 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 58.88 | 84.90 | 4666 | 7291 | 0.6399 | 0.8657 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 58.88 | 84.90 | 876 | 7291 | 0.1201 | 0.4381 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 58.88 | 84.90 | 6052 | 7291 | 0.8300 | 0.9428 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 60.59 | 84.90 | 2102 | 7641 | 0.2751 | 0.6394 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 60.59 | 84.90 | 4794 | 7641 | 0.6273 | 0.8614 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 60.59 | 84.90 | 679 | 7641 | 0.0889 | 0.3775 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 60.59 | 84.90 | 6193 | 7641 | 0.8104 | 0.9363 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 62.29 | 84.90 | 1884 | 7934 | 0.2374 | 0.6056 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 62.29 | 84.90 | 4891 | 7934 | 0.6164 | 0.8575 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 62.29 | 84.90 | 529 | 7934 | 0.0667 | 0.3224 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 62.29 | 84.90 | 6248 | 7934 | 0.7875 | 0.9283 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 63.99 | 84.90 | 1545 | 8212 | 0.1881 | 0.5525 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 63.99 | 84.90 | 5022 | 8212 | 0.6115 | 0.8563 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 63.99 | 84.90 | 446 | 8212 | 0.0543 | 0.2860 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 63.99 | 84.90 | 6315 | 8212 | 0.7690 | 0.9219 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 65.70 | 84.90 | 1396 | 8484 | 0.1645 | 0.5242 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 65.70 | 84.90 | 5041 | 8484 | 0.5942 | 0.8492 | MN20160318_Q02 | E06 |